AML
News
FDA approves ivosidenib frontline for certain AML patients
The expanded approval means that ivosidenib can be used first-line for acute myeloid leukemia patients with an IDH1 mutation who are not eligible...
Conference Coverage
Study highlights lack of data on transgender leukemia patients
NEWPORT BEACH, CALIF. – Researchers identified transgender leukemia patients by detecting gender-karyotype mismatches.
Video
ALF 2019 showcases evolving treatment of AML
NEWPORT BEACH, CALIF. – Dr. Martin Tallman discusses meeting presentations on the treatment of AML.
News
Azacitidine-nivolumab combo 'encouraging' in AML
The response rate was higher among patients who had not received prior treatment with hypomethylating agents.
News
Pruritus linked to wide variety of cancers
The odds of specific cancers vary by race.
News
FDA fast-tracks CX-01 for newly diagnosed AML
News
Mutations may be detectable years before AML diagnosis
The results suggest that monitoring strategies should be studied.
News
A global snapshot of leukemia incidence
United States is on the high side for all four subtypes of the disease.
News
10 recommendations for the Cancer Moonshot
Responding to the Cancer Moonshot initiative, a panel of scientists, clinicians, patient advocates, and industry representatives has issued 10...